These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25261554)

  • 1. Reply to Leithner et al.: Focus on phopshoenolpyruvate carboxykinase (PEPCK): a target of the p53-SIRT6-FoxO1 axis.
    Li Z; Zhu WG
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4395. PubMed ID: 25261554
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.
    Zhang P; Tu B; Wang H; Cao Z; Tang M; Zhang C; Gu B; Li Z; Wang L; Yang Y; Zhao Y; Wang H; Luo J; Deng CX; Gao B; Roeder RG; Zhu WG
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10684-9. PubMed ID: 25009184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gluconeogenesis in cancer: door wide open.
    Leithner K; Hrzenjak A; Olschewski H
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4394. PubMed ID: 25261555
    [No Abstract]   [Full Text] [Related]  

  • 4. A two-step pathway to resist fasting.
    Kaestner KH
    Cell Metab; 2008 Dec; 8(6):449-51. PubMed ID: 19041759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin suppresses sirtuin 6 through miR-495, increasing FoxO1-dependent hepatic gluconeogenesis.
    Shi MY; Bang IH; Han CY; Lee DH; Park BH; Bae EJ
    Theranostics; 2020; 10(25):11416-11427. PubMed ID: 33052223
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes.
    Frescas D; Valenti L; Accili D
    J Biol Chem; 2005 May; 280(21):20589-95. PubMed ID: 15788402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells.
    Shukla S; Sharma A; Pandey VK; Raisuddin S; Kakkar P
    Toxicol Appl Pharmacol; 2016 Jan; 291():70-83. PubMed ID: 26712469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.
    Khongkow M; Olmos Y; Gong C; Gomes AR; Monteiro LJ; Yagüe E; Cavaco TB; Khongkow P; Man EP; Laohasinnarong S; Koo CY; Harada-Shoji N; Tsang JW; Coombes RC; Schwer B; Khoo US; Lam EW
    Carcinogenesis; 2013 Jul; 34(7):1476-86. PubMed ID: 23514751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.
    Xiong X; Tao R; DePinho RA; Dong XC
    PLoS One; 2013; 8(8):e74340. PubMed ID: 24015318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gluconeogenesis Alteration and p53-SIRT6-Fox01 Signaling Adaptive Regulation in Sheep from Different Grazing Periods.
    Han Y; Liang C; Yu Y; Zhang J; Wang J; Cao J
    Comput Math Methods Med; 2022; 2022():4614665. PubMed ID: 35936357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.
    Schilling MM; Oeser JK; Boustead JN; Flemming BP; O'Brien RM
    Nature; 2006 Oct; 443(7111):E10-1. PubMed ID: 17024043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis.
    Li M; Hou T; Gao T; Lu X; Yang Q; Zhu Q; Li Z; Liu C; Mu G; Liu G; Bao Y; Wen H; Wang L; Wang H; Zhao Y; Gu W; Yang Y; Zhu WG
    Cell Death Dis; 2018 Sep; 9(10):941. PubMed ID: 30237540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis.
    Shin DJ; Joshi P; Hong SH; Mosure K; Shin DG; Osborne TF
    Nucleic Acids Res; 2012 Dec; 40(22):11499-509. PubMed ID: 23066095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development.
    Sekine K; Chen YR; Kojima N; Ogata K; Fukamizu A; Miyajima A
    EMBO J; 2007 Aug; 26(15):3607-15. PubMed ID: 17627282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.
    Fu W; Ma Q; Chen L; Li P; Zhang M; Ramamoorthy S; Nawaz Z; Shimojima T; Wang H; Yang Y; Shen Z; Zhang Y; Zhang X; Nicosia SV; Zhang Y; Pledger JW; Chen J; Bai W
    J Biol Chem; 2009 May; 284(21):13987-4000. PubMed ID: 19321440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver.
    Park JM; Kim TH; Bae JS; Kim MY; Kim KS; Ahn YH
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):329-34. PubMed ID: 21078299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage.
    Huang H; Regan KM; Lou Z; Chen J; Tindall DJ
    Science; 2006 Oct; 314(5797):294-7. PubMed ID: 17038621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-dependent SIRT6 expression protects Aβ42-induced DNA damage.
    Jung ES; Choi H; Song H; Hwang YJ; Kim A; Ryu H; Mook-Jung I
    Sci Rep; 2016 May; 6():25628. PubMed ID: 27156849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
    Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
    J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6.
    Wood M; Rymarchyk S; Zheng S; Cen Y
    Arch Biochem Biophys; 2018 Jan; 638():8-17. PubMed ID: 29233643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.